Pharma IQ Members

Informatics

Find out which informatics are right for your lab. Pharma IQ is proud to provide an international, non-biased, central resource, for professionals working in pharmaceutical, biotech and life science laboratories to exchange ideas on best practice and share case studies on laboratory innovation and automation within the area.

Contributor: Deborah Blaxell (Legal Consultant) and Martin Bonney ( International Director, Consulting Services) Epiq Systems
Posted: 14/06/2015
Enterprise Messaging – Mapping The Maze
Today’s working environment is increasingly dominated by the use of mobile and social media, raising important implications for corporate data management. Mobile media is firmly integrated into our everyday activities, enabling convergence between our working lives and personal social media. The rise of enterprise social networking sites such as Jive, SharePoint and Yammer has contributed to the growth of corporate data volumes by forty percent (40%) annually[1] as organisations move an increasing number of tasks and content over to these collaborative platforms. Full Article »
Contributor: Gerald Clarke
Posted: 24/03/2014
The informatics landscape is changing quickly and innovation could be the key to increasing efficiency. Jeff Hurst, Senior Scientist at the Hershey's Company talks us through these changes and how the industry is moving away from robots towards more innovative methods including mobile apps. He also talks about the dangers of becoming overly ' Full Podcast »
Contributor: Andrew Love
Posted: 10/09/2014
Andrew Love
In the final article in his serialisation series, Andrew Love looks at what needs to be done to commence the development of your strategy and implementation of your solutions. Andrew outlines the challenges you are likely to face such as identifying and interpreting the emerging and evolving legislation or Understanding the immature and evolving solution supply base and selecting appropriate implementation partners. He outlines solutions to these problems to clear your path to serialisation implementation Full Column »
Posted: 29/06/2015
Fake pharmaceuticals have the potential to be harmful for consumption. This possibility was seen back in 2013 when the FDA alerted the industry of the existence of a counterfeit cancer medicine that was distributed in the US. The regulator advised against its use due to concerns that the pharmaceutical may have been unsafe or ineffective.

In this 2015 Serialisation Report, Pharma IQ presents the findings of its latest industry survey while drawing trends on previous years to explore the shifts in industry consensus.

Plus, Pharma IQ presents its printable Serialisation Deadline WorldmapIn this 2015 Serialisation Report, Pharma IQ presents the findings of its latest industry survey while drawing trends on previous years to explore the shifts in industry consensus. Plus, Pharma IQ presents its printable Serialisation Deadline Worldmap. Full Whitepaper »